<< Read Full Article
<< Read Full Article
The Biotech Stock Mailbag is open.
Randall H. writes, "You recently did an article on rheumatoid arthritis. Have you looked at the drugs coming out from Chelsea Therapeutics(CHTP Quote)? They have two drugs, CH1504 and CH4051 that are similar to methotrexate, but without the liver toxicity due to them being metabolically inert. Do you feel either of these drugs have a shot?"
Methotrexate is a standard and widely used treatment for rheumatoid arthritis. The drug is also generic. All these factors present a challenge for any drugmaker seeking to develop a methotrexate alternative. ...
Recent Comments
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,388.90 | 1,105.98 | 2,194.35 | 34.83 |
Oil *
77.74
|
|
UP
22.75
|
UP
6.06
|
UP
21.21
|
UP
1.03
|
10 Yr
3.48%
SPDR Gold
113.75
|
|
+0.22%
|
+0.55%
|
+0.98%
|
+3.05%
|
Data delayed 20 minutes |


Connect with TheStreet